Persistent Asset Partners’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$94.5K Buy
+2,541
New +$151K 0.03% 298

Other funds holding XENE

Persistent Asset Partners's XENE Position: Q3 2026 in Review

Persistent Asset Partners opened a new position in Xenon Pharmaceuticals (XENE) in Q3 2026: 2,541 shares worth $94.5K. The stake represents 0.03% of the portfolio and ranks #298 among its holdings.

286 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • Persistent Asset Partners held 2,541 shares of Xenon Pharmaceuticals worth $94.5K as of Q3 2026.
  • Xenon Pharmaceuticals was a new Persistent Asset Partners position in Q3 2026.
  • Xenon Pharmaceuticals made up 0.03% of Persistent Asset Partners's portfolio in Q3 2026, its #298 holding.
  • 286 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.